Chiome Bioscience
Business Services · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Sumitomo Fudosan Nishi-Shinjuku Bldg No ...Phone Number
+81 363833561Website
www.chiome.co.jpRevenue
<$5 MillionStock Symbol
4583Industry
About Chiome Bioscience
Chiome Bioscience Org Chart
Is Chiome Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Chiome Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Chiome Bioscience has new funding data
Check if Chiome Bioscience has recently received funding, and reach out quickly before it becomes old news!
Click to see if Chiome Bioscience had a recent Job posting/layoffs
Check out if Chiome Bioscience is spiking on competitors!
Product Launch: Get notified when Chiome Bioscience launches new products
Congratulate Masked Content for being promoted to Masked Content at Chiome Bioscience
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Chiome Bioscience recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Chiome Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Chiome Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Chiome Bioscience.
Chiome Bioscience Tech Stack
A closer look at the technologies used by Chiome Bioscience
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Chiome Bioscience
Chiome Bioscience Inc. focuses on accelerating drug discovery and development of monoclonal antibodies (mAb) to address unmet medical needs. The company leverages its proprietary ADLib system and unique antibody production technology as part of its innovative platform. Their business strategy emphasizes overcoming current challenges in therapeutics... Read More